|
1
|
Karatzas A, Tzortzis V, Giannatou E,
Gravas S, Zachos I, Oeconomou A, Melekos M and Tsezou A: Lack of
association between the UDP-glucuronosyltransferase 1A1 (UGT1A1)
gene polymorphism and the risk of benign prostatic hyperplasia in
Caucasian men. Mol Biol Rep. 40:6665–6669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roehrborn CG and Rosen RC: Medical therapy
options for aging men with benign prostatic hyperplasia: Focus on
alfuzosin 10 mg once daily. Clin Interv Aging. 3:511–524.
2008.PubMed/NCBI
|
|
3
|
Roehrborn CG: Male lower urinary tract
symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin
North Am. 95:87–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bianco JJ, McPherson SJ, Wang H, Prins GS
and Risbridger GP: Transient neonatal estrogen exposure to
estrogen-deficient mice (aromatase knockout) reduces prostate
weight and induces inflammation in late life. Am J Pathol.
168:1869–1878. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prins GS and Korach KS: The role of
estrogens and estrogen receptors in normal prostate growth and
disease. Steroids. 73:233–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McPherson SJ, Ellem SJ and Risbridger GP:
Estrogen-regulated development and differentiation of the prostate.
Differentiation. 76:660–670. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Menasce LP, White GR, Harrison CJ and
Boyle JM: Localization of the estrogen receptor locus (ESR) to
chromosome 6q25.1 by FISH and a simple post-FISH banding technique.
Genomics. 17:263–265. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weihua Z, Makela S, Andersson LC, Salmi S,
Saji S, Webster JI, Jensen EV, Nilsson S, Warner M and Gustafsson
JA: A role for estrogen receptor beta in the regulation of growth
of the ventral prostate. Proc Natl Acad Sci USA. 98:6330–6335.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prins GS, Marmer M, Woodham C, Chang W,
Kuiper G, Gustafsson JA and Birch L: Estrogen receptor-beta
messenger ribonucleic acid ontogeny in the prostate of normal and
neonatally estrogenized rats. Endocrinology. 139:874–883. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krege JH, Hodgin JB, Couse JF, Enmark E,
Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA and Smithies
O: Generation and reproductive phenotypes of mice lacking estrogen
receptor beta. Proc Natl Acad Sci USA. 95:15677–15682. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ban JY and Yoo KH: Promoter polymorphism
(rs12770170, −184C/T) of microseminoprotein, beta as a risk factor
for benign prostatic hyperplasia in Korean population. Int
Neurourol J. 18:63–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoo KH, Kim SK, Chung JH and Chang SG:
Nitric oxide synthase 2 gene polymorphisms are associated with
prostatic volume in Korean men with benign prostatic hyperplasia.
Asian J Androl. 12:690–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ryan J, Carrière I, Amieva H, Rouaud O,
Berr C, Ritchie K, Scarabin PY and Ancelin ML: Prospective analysis
of the association between estrogen receptor gene variants and the
risk of cognitive decline in elderly women. Eur
Neuropsychopharmacol. 23:1763–1768. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marini H, Curro M, Adamo EB, Polito F,
Ferlazzo N, Bitto A, Atteritano M, D'Anna R, Alibrandi A, Altavilla
D, et al: The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is
associated with fibrinogen plasma levels in postmenopausal women.
Gene. 508:206–210. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kristiansen W, Andreassen KE, Karlsson R,
Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW,
Solberg A, et al: Gene variations in sex hormone pathways and the
risk of testicular germ cell tumour: A case-parent triad study in a
Norwegian-Swedish population. Hum Reprod. 27:1525–1535. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang TL, Xiong DH, Guo Y, Recker RR and
Deng HW: Comprehensive association analyses of IGF1, ESR2 and CYP17
genes with adult height in Caucasians. Eur J Hum Genet.
16:1380–1387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gabriel SB, Schaffner SF, Nguyen H, Moore
JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart
M, et al: The structure of haplotype blocks in the human genome.
Science. 296:2225–2229. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schuler S, Lattrich C, Skrzypczak M, Fehm
T, Ortmann O and Treeck O: Polymorphisms in the promoter region of
ESR2 gene and susceptibility to ovarian cancer. Gene. 546:283–287.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu Z, Wang G and Chen W: Estrogen receptor
alpha gene polymorphisms and risk of prostate cancer: A
meta-analysis involving 18 studies. Tumour Biol. 35:5921–5930.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chattopadhyay S, Siddiqui S, Akhtar MS,
Najm MZ, Deo SV, Shukla NK and Husain SA: Genetic polymorphisms of
ESR1, ESR2, CYP17A1 and CYP19A1 and the risk of breast cancer: A
case control study from North India. Tumour Biol. 35:4517–4527.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Attia DM and Ederveen AG: Opposing roles
of ERα and ERβ in the genesis and progression of adenocarcinoma in
the rat ventral prostate. Prostate. 72:1013–1022. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hammarsten J, Damber JE, Karlsson M,
Knutson T, Ljunggren O, Ohlsson C, Peeker R, Smith U and Mellström
D: Insulin and free oestradiol are independent risk factors for
benign prostatic hyperplasia. Prostate Cancer Prostatic Dis.
12:160–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
García-Flórez M, Oliveira CA and Carvalho
HF: Early effects of estrogen on the rat ventral prostate. Braz J
Med Biol Res. 38:487–497. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McPherson SJ, Hussain S, Balanathan P,
Hedwards SL, Niranjan B, Grant M, Chandrasiri UP, Toivanen R, Wang
Y, Taylor RA and Risbridger GP: Estrogen receptor-beta activated
apoptosis in benign hyperplasia and cancer of the prostate is
androgen independent and TNFalpha mediated. Proc Natl Acad Sci USA.
107:3123–3128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sadee W, Wang D, Papp AC, Pinsonneault JK,
Smith RM, Moyer RA and Johnson AD: Pharmacogenomics of the RNA
world: Structural RNA polymorphisms in drug therapy. Clin Pharmacol
Ther. 89:355–365. 2011. View Article : Google Scholar : PubMed/NCBI
|
